Home>Health>Cystic fibrosis drugs rejected for use by NHS in Scotland
Health

Cystic fibrosis drugs rejected for use by NHS in Scotland


Two cystic fibrosis drugs which have been described as “life-changing” by campaigners have been rejected for use by the NHS in Scotland.

The Scottish Medicines Consortium said there were uncertainties about the long-term health benefits of Orkambi and Symkevi in relation to their costs.

Both drugs are manufactured by Vertex.

It said it was working with the Scottish government to find a solution to allow broad access for eligible patients as a matter of urgency.



Source link

Review Overview

Summary